Overview
- The rebranded company, formerly Portage Biotech, began trading as ATON on Sept. 4 as it pivots to a dedicated Toncoin treasury strategy.
- Financing is expected to close around Sept. 5, with BitGo holding the TON collateral tied to the $35 million loan facility.
- Brittany Kaiser was named CEO and Enzo Villani became executive chairman and chief investment officer as the firm reshapes leadership for its crypto focus.
- AlphaTON plans to generate yield through staking and validation and to incubate mini-apps and DeFi projects within Telegram’s ecosystem.
- Shares jumped intraday on the announcement, while Toncoin’s market price showed limited movement despite the $100 million plan and similar corporate accumulation by peers such as TON Strategy Co, which disclosed $713 million in TON and a $250 million buyback program.